Navigation Links
Science survey ranks top biopharma employers
Date:10/1/2009

Science annual survey of Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries. Respondents to the web-based survey are asked to rate companies based on 23 driving characteristics, including financial strength, easy adaptation to change, and a research-driven environment.

This year, Genentech, Inc., of South San Francisco, California, again receives top honors in a ranking of the world's most respected biopharmaceutical employers. The company has placed first in seven out of eight years that Science has carried out this survey. Boehringer Ingelheim of Ingelheim, Germany, comes in a close second, with Genzyme of Cambridge, Massachusetts, completing the top three.

This year's survey identified 17 other top pharmaceutical and biotechnology companies, making up a top 20 of biopharma employers.

The rankings, determined from a study conducted by an independent research firm commissioned by the business office of the journal, will appear in a special business feature of the 2 October 2009 issue.

Like Science's 2008 ranking of biopharma employers, the 2009 survey sought to identify the companies with the best reputations as employers, based on over 2,300 survey responses from readers of Science and other respondents in industry. Survey participants came from North America (73%), Europe (15%), and the Pacific Rim (8%); 85 percent worked in private industry.

Survey responses were analyzed by The Brighton Consulting Group, which used a mathematical process to assign a unique score to rate the companies' employer reputation. Each company received a ranking, for example, on the basis of whether it treats its employees with respect, whether its work-culture values align with employees' personal values, and other factors.


'/>"/>

Contact: Natasha Pinol
npinol@aaas.org
202-326-7088
American Association for the Advancement of Science
Source:Eurekalert

Page: 1

Related biology news :

1. National Science Foundation funds systems biology study of crop drought responses
2. Combining sun, sand and science in the Bahamas
3. Bio-optics breakthroughs: Highlights of medical and bioscience research at Frontiers in Optics 2009
4. Geological Society of America honors Judge Jones for upholding science in the classroom
5. Dr. Richard Feinman to speak on the science of diabetes and diet on Oct. 2
6. Louisiana Tech University receives grant to advance women in engineering, science
7. Wisconsin Center of Excellence in Genomics Science established
8. MSU licenses plant oil enhancement technology to BASF Plant Science
9. WPI receives $1.3 million in federal awards for ongoing research in the life sciences
10. Synthetic Biology Project receives 2 National Science Foundation grants
11. Science Coalition commends Presidents strategy for innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/15/2016)... LONDON , Dec. 15, 2016 /PRNewswire/ ... the driving experience, health wellness and wellbeing ... As one in three new passenger vehicles ... voice recognition, gesture recognition, heart beat monitoring, ... eyelid monitoring, facial monitoring, and pulse detection. ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the growth of ... expected to grow from USD 4.03 billion in 2015 ... of 29.3% between 2016 and 2022. The market is ... smart devices, government initiatives, and increasing penetration of e-commerce ... to grow at a high rate during the forecast ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... has initiated a global Phase 2b induction study ... that targets alpha4beta7 integrin. The aim of this ... evaluate the safety/tolerability and efficacy of PTG-100 in ... to severe active disease. "We ...
(Date:1/16/2017)... , Jan. 16, 2017   Valentin A. Pavlov, ... MD , president and CEO of The Feinstein ... an analysis of how the nervous system regulates the ... develop bioelectronic medicine devices to treat disease ... Nature Neuroscience . The paper examines various ...
(Date:1/14/2017)... ... January 14, 2017 , ... Seattle-based Phase ... end-to-end genome assemblies to researchers around the globe. Long considered a “holy ... answering a wide range of scientific questions. The announcement was made today ...
(Date:1/13/2017)... Research and Markets has announced the addition of the "Global Biopolymers ... ... of 16.83% during the period 2017-2021. The report covers ... for 2017-2021. To calculate the market size, the report considers the revenue ... includes a a discussion of the key vendors operating in this market. ...
Breaking Biology Technology: